Non-Vitamin k antagonist oral anticoagulants an appeal for consensus on terminology

Chest

Volumn 145, Issue 5, 2014, Pages 1177-1178

  Lip, Gregory Y H ^a   Camm, A John ^b   Hylek, Elaine M ^c   Halperin, Jonathan L ^c   Weitz, Jeffrey I ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Citi   (United Kingdom)

^c BOSTON UNIVERSITY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; EDOXABAN; RIVAROXABAN; THROMBIN INHIBITOR; WARFARIN;

ACUTE CORONARY SYNDROME; CEREBROVASCULAR ACCIDENT; CONSENSUS; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG INDICATION; DRUG MARKETING; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

ACENOCOUMAROL; ADMINISTRATION, ORAL; ANTICOAGULANTS; CONSENSUS; HUMANS; TERMINOLOGY AS TOPIC; THROMBOSIS; VITAMIN K;

EID: 84899746460     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2951     Document Type: Letter

References (5)

1. De Caterina R , Husted S , Wallentin L , et al ; European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease . General mechanisms of coagulation and targets of anticoagulants (section I). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease . Thromb Haemost . 2013 ; 109 (4): 569-579.
2. De Caterina R , Husted S , Wallentin L , et al . Vitamin K antagonists in heart disease: current status and perspectives (section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease . Thromb Haemost . 2013 ; 110 (6): 1087-1107.
3. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest . 2012;141(2-suppl):e44S-88S .
4. Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest . 2012;141(2-suppl): e120S-151S .
5. Heidbuchel H , Verhamme P , Alings M , et al ; European Heart Rhythm Association . European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fi brillation . Europace . 2013 ; 15 (5): 625-651.